Presentation ACC 2022 A Single Ascending Dose Study of an siRNA Targeting Lipoprotein(a) Presenter: Steven E. Nissen April 04, 2022 REGISTER for free or LOG IN to view this content Clinical Cardiology Prevention Clinical Pharma Coronary Presentation ACC 2022 Up Next Presentation ACC 2022 TRANSLATE-TIMI 70 Presenter: Brian Bergmark April 04, 2022 More slides + Presentation ACC 2022 Long Term Efficacy and Safety of Renal Denervation on Blood Pressure in Patients on Antihypertension Medications: 3-Year Outcomes from the SPYRAL HTN-ON MED Trial Presenter: Felix Mahfoud April 04, 2022 Presentation ACC 2022 The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic Heart Failure And Reduced Ejection Fraction: METEORIC-HF Presenter: Michael Felker April 04, 2022 We Recommend
Presentation ACC 2022 Long Term Efficacy and Safety of Renal Denervation on Blood Pressure in Patients on Antihypertension Medications: 3-Year Outcomes from the SPYRAL HTN-ON MED Trial Presenter: Felix Mahfoud April 04, 2022
Presentation ACC 2022 The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic Heart Failure And Reduced Ejection Fraction: METEORIC-HF Presenter: Michael Felker April 04, 2022